Parkinson's disease trials recruiting in Oregon

All Parkinson's disease trials nationally

Cities in Oregon

Recruiting trials in Oregon

• A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
  NCT06680830 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Oregon: Portland
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
  NCT06976268 · Phase: Phase 2, Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Oregon: Portland
• A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
  NCT07174310 · Phase: Phase 3 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Oregon: Portland
• A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
  NCT06944522 · Phase: Phase 3 · Ages: 45 Years to 75 Years · Sex: All (male and female) · Oregon: Portland
• Balance Tele-Rehab in Parkinson's Disease
  NCT05680597 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years to 85 Years · Sex: All (male and female) · Oregon: Portland
• Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
  NCT07204652 · Phase: Not specified · Ages: 40 Years to 99 Years · Sex: All (male and female) · Oregon: Portland
• Cortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing
  NCT05818189 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 85 Years · Sex: All (male and female) · Oregon: Portland
• PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
  NCT04477785 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female) · Oregon: Portland
• Parkinson's Foundation PD GENEration Genetic Registry
  NCT04994015 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Oregon: Portland
• Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease
  NCT06772220 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 90 Years · Sex: All (male and female) · Oregon: Portland
• Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
  NCT04373317 · Phase: Phase 4 · Ages: 40 Years and older · Sex: All (male and female) · Oregon: Portland
• The GBA Multimodal Study in Parkinson's Disease
  NCT04101968 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · Oregon: Portland
• The Parkinson's Genetic Research Study
  NCT01558479 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Oregon: Portland